<doc>
  <docmeta id="113s2126is">
    <bill congress="113" type="s" number="2126" version="is"/>
    <revision size="8288" annotations="0" status="complete" id="3" commit-time="2014-03-25T18:06:30Z" committer="mbohmer" doc="113s2126is/3.xml">
      <description>Edited via AKN</description>
    </revision>
  </docmeta>
  <bill bill-stage="Introduced-in-Senate" public-private="public">
	<metadata>
<dublinCore>
<dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">113 S2126 IS: Regenerative Medicine Promotion Act of 2014</dc:title>
<dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">U.S. Senate</dc:publisher>
<dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2014-03-13</dc:date>
<dc:format xmlns:dc="http://purl.org/dc/elements/1.1/">text/xml</dc:format>
<dc:language xmlns:dc="http://purl.org/dc/elements/1.1/">EN</dc:language>
<dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/">Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
		<distribution-code display="yes">II</distribution-code>
		<congress>113th CONGRESS</congress>
		<session>2d Session</session>
		<legis-num>S. 2126</legis-num>
		<current-chamber>IN THE SENATE OF THE UNITED STATES</current-chamber>
		<action>
			<action-date date="20140313">March 13, 2014</action-date>
			<action-desc>
        <sponsor name-id="S223">Mrs. Boxer</sponsor> (for herself and <cosponsor name-id="S339">Mr. Kirk</cosponsor>) introduced the following bill; which was read twice and referred to the <committee-name committee-id="SSHR00">Committee on Health, Education, Labor, and Pensions</committee-name>
      </action-desc>
		</action>
		<legis-type>A BILL</legis-type>
		<official-title>To launch a national strategy to support regenerative medicine through the establishment of a
			 Regenerative Medicine Coordinating Council, and for other purposes.</official-title>
	</form>
	<legis-body id="HAD87D55459044704810FC2D7AD4AD883" style="OLC">
		<section id="HF4A701B135994F54882BB21B3C4D6546" section-type="section-one">
			<enum>1.</enum>
			<header>Short title</header>
			<text display-inline="no-display-inline">This Act may be cited as the
			 <quote>
          <short-title>
            <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Regenerative Medicine Promotion Act of 2014" proposed="true">Regenerative Medicine Promotion Act of 2014</cato:entity-ref>
          </short-title>
        </quote>.</text>
		</section>
    <section id="HCC3271438CB7458991F56CBE5BFDB8F2">
			<enum>2.</enum>
			<header>Findings</header>
			<text display-inline="no-display-inline">
        <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="0001">Congress</cato:entity-ref> finds the following:</text>
			<paragraph id="H4E4B41426414474AA3F5C7D42B310FB2">
				<enum>(1)</enum>
				<text display-inline="yes-display-inline">Regenerative medicine has the potential to
			 treat many chronic diseases, promote economic growth, and reduce health
			 care
			 spending in the United States.</text>
			</paragraph>
      <paragraph id="HBE5F35F666F34E4D9A3B91FB9280FD53">
				<enum>(2)</enum>
				<text>Regenerative
			 medicine products have already successfully treated numerous health
			 conditions
			 and have the potential to provide cures, treatments and diagnostics for a
			 range
			 of diseases and disabilities including diabetes, spinal cord injury, heart
			 disease, stroke, various forms of cancer, and other age-related conditions
			 that
			 represent a huge quality of life, social, and economic burden on
			 society.</text>
			</paragraph>
      <paragraph id="ID8d95207e28264cc69bb7071c0968b0dc">
				<enum>(3)</enum>
				<text>A United States
			 national strategy on regenerative medicine is critical to ensure that this
			 technology fulfills its potential to cure and treat diseases and
			 disabilities,
			 reduce overall health care spending, and promote economic growth.</text>
			</paragraph>
      <paragraph id="HFB61ED8F3B874D3F89D111ED3E2DED09">
				<enum>(4)</enum>
				<text>The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="9700">Department of
			 Defense</cato:entity-ref> has stated that regenerative medicine has the potential to treat
			 many
			 battlefield injuries such as burns, that it has the potential to heal
			 wounds
			 without scarring, and that it has the potential to be used for
			 craniofacial
			 reconstruction, limb reconstruction, regeneration, and transplantation.</text>
			</paragraph>
      <paragraph id="H65825A612C814414ADBB179253E3EF4E">
				<enum>(5)</enum>
				<text display-inline="yes-display-inline">The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Department of Health and Human Services</cato:entity-ref>
			 and the Multi-Agency Tissue Engineering Science Interagency Working Group
			 have
			 endorsed a national initiative to support research and product development
			 in
			 regenerative medicine.</text>
			</paragraph>
      <paragraph id="HDBC13EC5C0914C02AE7BA40AD901C659">
				<enum>(6)</enum>
				<text>The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Department of
			 Health and Human Services</cato:entity-ref> has said the potential benefits of regenerative
			 medicine in improved health care and economic savings are enormous. States
			 that
			 have invested in regenerative medicine have experienced economic growth
			 and see
			 future growth potential, including an increase in biotech employment,
			 payroll
			 increases, and proportional impacts on tax receipts.</text>
      </paragraph>
    </section>
    <section commented="no" display-inline="no-display-inline" id="H6642FE961E79448CA36C2E9FB0266320" section-type="subsequent-section">
      <enum>3.</enum>
      <header display-inline="yes-display-inline">Report on ongoing
			 Federal programs and activities regarding regenerative medicine</header>
      <text display-inline="no-display-inline">Not later than 90 days after the date of the
			 enactment of this Act, the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="0500">Comptroller General of the United States</cato:entity-ref> shall
			 provide for the completion, and submission to <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="0001">Congress</cato:entity-ref>, of a report
			 identifying
			 all ongoing Federal programs and activities regarding regenerative
			 medicine.</text>
    </section>
    <section display-inline="no-display-inline" id="HD949A4D34C544FBE8C6C86B8422B99A7">
			<enum>4.</enum>
			<header>Establishment of
			 Regenerative Medicine Coordinating Council</header>
			<subsection id="H43FB6648C5BC44C7BC6E8BA0806CE4CE">
				<enum>(a)</enum>
				<header>Establishment</header>
				<text display-inline="yes-display-inline">The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary of Health and Human Services</cato:entity-ref>
			 shall establish, in the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7501">Office of the Secretary</cato:entity-ref>, a <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Regenerative Medicine Coordinating Council" entity-parent-id="750S" proposed="true">Regenerative Medicine
			 Coordinating Council</cato:entity-ref> (in this section referred to as the
			 <quote>Council</quote>).</text>
			</subsection>
      <subsection id="HB12DD433B06E40F09CC412D472CAB69A">
				<enum>(b)</enum>
				<header>Composition</header>
				<text display-inline="yes-display-inline">The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Regenerative Medicine Coordinating Council" entity-parent-id="750S" proposed="true">Council</cato:entity-ref> shall be composed of the
			 following:</text>
				<paragraph id="HD47F02D75D104BC98B9DA2CFF4E00104">
					<enum>(1)</enum>
					<text>The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="1300">Secretary of
			 Commerce</cato:entity-ref>.</text>
				</paragraph>
        <paragraph id="HC33D6AF6F7A24EE79B83BE693B830337">
					<enum>(2)</enum>
					<text>The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="9700">Secretary of
			 Defense</cato:entity-ref>.</text>
				</paragraph>
        <paragraph id="HF33034AEF0F542D6B131269B2D85902A">
					<enum>(3)</enum>
					<text display-inline="yes-display-inline">The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary of Health and Human
			 Services</cato:entity-ref>.</text>
				</paragraph>
        <paragraph id="HC8CA609F0AE74B0799334944F3292908">
					<enum>(4)</enum>
					<text>The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="2000">Secretary of
			 the Treasury</cato:entity-ref>.</text>
				</paragraph>
        <paragraph id="HCBAD42B168744212B8F85CBF47F8D8DC">
					<enum>(5)</enum>
					<text>The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="3600">Secretary of
			 Veterans Affairs</cato:entity-ref>.</text>
				</paragraph>
        <paragraph id="H4EFF91418A9043A69CA28BB96F96CB95">
					<enum>(6)</enum>
					<text>The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7528">Administrator
			 of the Agency for Healthcare Research and Quality</cato:entity-ref>.</text>
				</paragraph>
        <paragraph id="H3D6AB064DE174AFBB9AC5F806885D771">
					<enum>(7)</enum>
					<text>The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7530">Administrator
			 of the Centers for Medicare &amp; Medicaid Services</cato:entity-ref>.</text>
				</paragraph>
        <paragraph id="H3F6347B9B042491A8FC205B02F47544F">
					<enum>(8)</enum>
					<text>The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7524">Commissioner
			 of Food and Drugs</cato:entity-ref>.</text>
				</paragraph>
        <paragraph id="H31605E69D3E24F79B9A6EB49781F0E83">
					<enum>(9)</enum>
					<text display-inline="yes-display-inline">The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7529">Director of the National Institutes of
			 Health</cato:entity-ref>.</text>
				</paragraph>
        <paragraph id="HF88660B2E7A74C57AFB7015D1D42ECE4">
					<enum>(10)</enum>
					<text display-inline="yes-display-inline">The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="1341">Director of the National Institutes of
			 Standards and Technology</cato:entity-ref>.</text>
				</paragraph>
        <paragraph id="H8EBD484065DE4BCDAD1583B1AF1DE204">
					<enum>(11)</enum>
					<text>Such other
			 members as may be appointed by the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary of Health and Human
			 Services</cato:entity-ref>.</text>
				</paragraph>
      </subsection>
      <subsection id="H0D6263D3BB154AE287072D8969C1D3E4">
				<enum>(c)</enum>
				<header>Chair</header>
				<text display-inline="yes-display-inline">The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary of Health and Human Services</cato:entity-ref>
			 shall be the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Regenerative Medicine Coordinating Council" entity-parent-id="750S" proposed="true">Chair of the Council</cato:entity-ref>.</text>
			</subsection>
      <subsection display-inline="no-display-inline" id="H164719FFA34D44B89E8580890D63ABED">
				<enum>(d)</enum>
				<header>Members
			 appointed by Secretary</header>
				<text display-inline="yes-display-inline">The
			 members of the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Regenerative Medicine Coordinating Council" entity-parent-id="750S" proposed="true">Council</cato:entity-ref> appointed by the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary of Health and Human
			 Services</cato:entity-ref>
			 under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Regenerative Medicine Promotion Act of 2014/s:4/ss:b/p:11" proposed="true">subsection (b)(11)</cato:entity-ref> shall include health insurers, regenerative
			 medicine
			 researchers from academic institutions, patient advocates, persons with
			 expertise in drug discovery, persons with expertise in drug development,
			 persons with expertise in basic research, persons with expertise in
			 translational research, persons with expertise in medical device
			 development,
			 persons with expertise in biomaterials, and persons with expertise in
			 clinical
			 research.</text>
			</subsection>
      <subsection id="H7327C1AFCD934CE696A0308473D65686">
				<enum>(e)</enum>
				<header>Functions</header>
				<text>The
			 <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Regenerative Medicine Coordinating Council" entity-parent-id="750S" proposed="true">Council</cato:entity-ref> shall—</text>
				<paragraph id="H921482C96CDD4123AB3A80F0E7E3D1BD">
					<enum>(1)</enum>
					<text display-inline="yes-display-inline">prepare, and keep up-to-date, a national
			 strategy to support research into regenerative medicine and enable the
			 development of drugs, biological products, medical devices, and
			 biomaterials
			 for use in regenerative medicine;</text>
				</paragraph>
        <paragraph id="id4423DC50A41F4390BB9F0500C52647FC">
					<enum>(2)</enum>
					<text>develop national
			 goals for regenerative medicine research and product development;</text>
				</paragraph>
        <paragraph id="H36177E3C801D45B7B5D33352FE7A1C82">
					<enum>(3)</enum>
					<text>prepare a plan
			 specifying priorities for research into regenerative medicine;</text>
				</paragraph>
        <paragraph id="HA467AC10051147CC8B6EA29355FE3208">
					<enum>(4)</enum>
					<text>identify sources
			 of funding for research into regenerative medicine;</text>
				</paragraph>
        <paragraph id="HB7EC9E33DB1646058BD61D506EE8527C">
					<enum>(5)</enum>
					<text>identify areas
			 where such funding is inadequate or duplicative;</text>
				</paragraph>
        <paragraph id="H6741674AEBEC49C89D2133C378F6E7A3">
					<enum>(6)</enum>
					<text display-inline="yes-display-inline">make recommendations regarding Federal
			 regulatory, reimbursement, and other policies that will support
			 development and
			 marketing of regenerative medicine products;</text>
				</paragraph>
        <paragraph commented="no" id="HDCE4F8B328084B4FA56955B3AC2DF365">
					<enum>(7)</enum>
					<text display-inline="yes-display-inline">develop consensus standards regarding
			 scientific issues critical to regulatory approval of regenerative medicine
			 products; and</text>
				</paragraph>
        <paragraph commented="no" id="H6FA778E1CF6C4DABB9DF1208040185DB">
					<enum>(8)</enum>
					<text>determine the need
			 for establishing centers of excellence or consortia to further advance
			 regenerative medicine.</text>
				</paragraph>
      </subsection>
      <subsection id="HF94700F84B8243E68991CC379CE8E7DE">
				<enum>(f)</enum>
				<header>Transparency;
			 reporting requirements</header>
				<paragraph id="HC0E46F08382A4AC4ACA8266975C32685">
					<enum>(1)</enum>
					<header>Transparency</header>
					<text>The
			 <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Regenerative Medicine Coordinating Council" entity-parent-id="750S" proposed="true">Council</cato:entity-ref> shall adopt procedures to ensure the receipt of public input, such
			 as
			 holding public stakeholder meetings or creating advisory boards.</text>
				</paragraph>
        <paragraph id="H18425E28A10A4AEE91B1AD94AB1C5AF7">
					<enum>(2)</enum>
					<header>Annual
			 reports</header>
					<text display-inline="yes-display-inline">The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Regenerative Medicine Coordinating Council" entity-parent-id="750S" proposed="true">Council</cato:entity-ref> shall
			 submit an annual report on its activities to <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="0001">Congress</cato:entity-ref>, the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7529">Director of the
			 National Institutes of Health</cato:entity-ref>, and the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7524">Commissioner of Food and Drugs</cato:entity-ref>.
			 Each
			 such report shall—</text>
					<subparagraph id="H61967A40B3E44232A9F4C3C3A2066FEE">
						<enum>(A)</enum>
						<text>provide details on
			 progress in meeting goals identified by the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Regenerative Medicine Coordinating Council" entity-parent-id="750S" proposed="true">Council</cato:entity-ref> for regenerative
			 medicine;</text>
					</subparagraph>
          <subparagraph id="ID78629c5df251498a837d5c3eaaf9f51e">
						<enum>(B)</enum>
						<text>provide
			 recommendations regarding funding, regulatory, or other policies to
			 achieve
			 regenerative medicine goals identified by the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Regenerative Medicine Coordinating Council" entity-parent-id="750S" proposed="true">Council</cato:entity-ref>;</text>
					</subparagraph>
          <subparagraph id="H3EB9ED504FAA4EC99486FAD73A3FCC43">
						<enum>(C)</enum>
						<text>identify
			 regenerative medicine products currently on the market and those in
			 development;</text>
					</subparagraph>
          <subparagraph id="HCEB8A76AABD14F80B2A320AA13D8FE39">
						<enum>(D)</enum>
						<text>identify
			 regenerative medicine research and technological advances and discoveries
			 that
			 occurred in the previous year; and</text>
					</subparagraph>
          <subparagraph id="HB2DFED01EAF64A30A4F647C6783AE35F">
						<enum>(E)</enum>
						<text>assess the impact
			 of regenerative medicine on the Nation's economy, including with respect
			 to—</text>
						<clause id="H26F18AA9DB5E4DAEA07CE399F00418F2">
							<enum>(i)</enum>
							<text>the
			 number of people employed in companies or research institutions working in
			 regenerative medicine;</text>
						</clause>
            <clause id="H3D1FF06A54F74BE8BE2B2889A78288E7">
							<enum>(ii)</enum>
							<text>the
			 number of companies pursuing regenerative medicine products; and</text>
						</clause>
            <clause id="HB7E7FEF2B04E4712A5A5A2E9D66A6A24">
							<enum>(iii)</enum>
							<text>increases in tax
			 revenues.</text>
						</clause>
          </subparagraph>
        </paragraph>
      </subsection>
    </section>
  </legis-body>
</bill>
</doc>